OraSure Announces 2016 First Quarter Financial Results

Go back to OraSure Announces 2016 First Quarter Financial Results

OraSure Technologies (OSUR) Fundamentals Intact - Mizuho

May 5, 2016 6:39 AM EDT

Mizuho analyst, Eric Criscuolo, sees a lot of opportunity for HCV and the Molecular Businesses leading him to reiterate his Buy rating on OraSure Technologies (NASDAQ: OSUR) even though the quarter wasn't stand out. The core growth drivers of molecular and HCV continue to... More

OraSure Technologies (OSUR) Tops Q1 EPS by 2c

May 4, 2016 5:21 PM EDT

OraSure Technologies (NASDAQ: OSUR) reported Q1 EPS of $0.04, $0.02 better than the analyst estimate of $0.02. Revenue for the quarter came in at $29.1 million versus the consensus estimate of $28.82 million.

For earnings history and earnings-related data on OraSure Technologies (OSUR) click here.

... More